108 -2 (88) 2026 - Juraeva G.T., Najmutdinova D.K. - CRITERIA FOR EARLY DIAGNOSIS AND OPTIMIZATION OF TREATMENT OF IRON DEFICIT CONDITIONS IN PREGNANT WOMEN

CRITERIA FOR EARLY DIAGNOSIS AND OPTIMIZATION OF TREATMENT OF IRON DEFICIT CONDITIONS IN PREGNANT WOMEN

Juraeva G.T. - Tashkent State Medical University

Najmutdinova D.K. - Tashkent State Medical University

Resume

Iron deficiency states in pregnant women remain highly prevalent and represent a significant risk factor for obstetric and perinatal complications. According to the recommendations of the International Federation of Gynecology and Obstetrics (FIGO), maternal anemia is a major risk factor in postpartum hemorrhage. Anemia reduces the oxygen-carrying capacity of the blood and impairs compensatory physiological mechanisms; as a result, even moderate blood loss (approximately 250 mL) in severely anemic women may lead to marked hemodynamic instability, whereas in women without anemia blood loss of up to approximately 1000 mL is generally tolerated with significantly fewer adverse consequences. These data underscore the importance of preventing and correcting anemia prior to delivery in order to reduce the risk of complications associated with obstetric hemorrhage. Diagnostic approaches commonly used in clinical practice, which are predominantly based on hemoglobin concentration, do not allow early stages of iron deficiency to be identified or the effectiveness of ongoing therapy to be adequately assessed.

Keywords: pregnancy, iron deficiency, iron deficiency anemia, ferritin, hepcidin; transferrin saturation, ferric carboxymaltose, cerebroplacental ratio.

First page

566

Last page

571

For citation:Juraeva G.T., Najmutdinova D.K. - CRITERIA FOR EARLY DIAGNOSIS AND OPTIMIZATION OF TREATMENT OF IRON DEFICIT CONDITIONS IN PREGNANT WOMEN//New Day in Medicine 2(88)2026 566-571 https://newdayworldmedicine.com/en/new_day_medicine/2-88-2026

List of References

1. FIGO Working Group on Good Clinical Practice in Maternal–Fetal Medicine. Management of iron deficiency and anemia in pregnancy and the postpartum period. Int J Gynecol Obstet. 2019;146(1):1–9.
2. Pavord S, Daru J, Prasannan N, Robinson S, Stanworth S, Girling J. UK guidelines on the management of iron deficiency in pregnancy. Br J Haematol. 2020;188(6):819–830.
3. Breymann C. Iron deficiency anemia in pregnancy. Semin Hematol. 2015;52(4):339–347.
4. Cappellini MD, Musallam KM, Taher AT. Iron deficiency anaemia revisited. J Intern Med. 2020;287(2):153–170.
5. Nemeth E, Ganz T. Hepcidin and iron-loading anemias. Haematologica. 2006;91(6):727–732.
6. Ganz T, Nemeth E. Iron homeostasis in host defence and inflammation. Nat Rev Immunol. 2015;15(8):500–510.
7. Achebe MM, Gafter-Gvili A. How I treat anemia in pregnancy: iron, cobalamin, and folate. Blood. 2017;129(8):940–949.
8. Van Wyck DB, Mangione A, Morrison J, Hadley PE, Jehle JA, Goodnough LT. Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia. Am J Hematol. 2009;84(9):615–619.
9. Breymann C, Milman N, Mezzacasa A, Bernard R, Dudenhausen J. Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia. J Perinat Med. 2017;45(4):443–453.
10. Джураева ГТ, Нажмутдинова ДК. Особенности диагностики и лечения анемии у беременных. Central Asian Journal of Medicine. 2025;1(8):344–353.
11. Hernandez-Andrade E, Figueras F, Oros D, et al. Cerebroplacental ratio in predicting adverse perinatal outcome. Ultrasound Obstet Gynecol. 2012;39(3):318–324.
12. Джураева ГТ, Нажмутдинова ДК, Атаходжаева ФА. Роль маркера гепсидина в диагностике железодефицитной анемии у беременных женщин. Journal of Education Scientific Medicine. 2019;(5):235–240.
13. Адамян ЛВ, Сухих ГТ, Радзинский ВЕ. Современные аспекты диагностики и коррекции дефицита железа при беременности. Вопросы гинекологии, акушерства и перинатологии. 2020;19(3):45–52.

    file

    download